The following table summarizes the computation of basic and diluted net (loss) income per share of the Company (in thousands, except share and per share data):


	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2026			2025			2026			2025

Net (loss) income, as reported	$	(1,504	)	$	(15,863	)	$	(24,544	)	$	27,225
Less: increase in available income		-			-			-			-
Diluted net loss	$	(1,504	)	$	(15,863	)	$	(24,544	)	$	27,225
Weighted average shares outstanding, basic		10,430,808			10,351,120			10,416,964			9,385,167
Add: Weighted average shares issuable		-			-			-			16,478
Weighted average shares outstanding, diluted		10,430,808			10,351,120			10,416,964			9,401,645
Net (loss) income per share - basic	$	(0.14	)	$	(1.53	)	$	(2.36	)	$	2.90
Net (loss) income per share - diluted	$	(0.14	)	$	(1.53	)	$	(2.36	)	$	2.90

For the six months ended June 30, 2025, the Company’s potentially dilutive securities include options to purchase common stock and unvested restricted stock. The 2023 common warrants and 2025 common warrants are antidilutive and excluded from the total weighted average shares outstanding, diluted.

The Company excluded the following potential shares of Common Stock, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2026		2025		2026		2025
Options to purchase common stock		2,138,459		1,086,761		2,138,459		893,331
Unvested restricted stock		80,388		17,264		80,388		14,316
Common warrants to purchase common stock		4,213,767		4,213,767		4,213,767		4,213,767
		6,432,614		5,317,792		6,432,614		5,121,414